Cancer with imrt. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Organs at Risk Cell Line, Tumor Prostate Neoplastic Stem Cells Breast Parotid Gland Tumor Cells, Cultured Rectum Pharyngeal Muscles HCT116 Cells MCF-7 Cells HT29 Cells Lymph Nodes Urogenital System

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases56

Prostatic Neoplasms Lung Neoplasms Breast Neoplasms Ovarian Neoplasms Head and Neck Neoplasms Radiation Injuries Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Pancreatic Neoplasms Neoplasm Invasiveness Carcinoma Carcinoma, Squamous Cell Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Genetic Predisposition to Disease Disease Progression Nasopharyngeal Neoplasms Xerostomia Neoplasm Recurrence, Local Urinary Bladder Neoplasms Rectal Neoplasms Colorectal Neoplasms Oropharyngeal Neoplasms Esophageal Neoplasms Neoplasms, Radiation-Induced Cell Transformation, Neoplastic Endometrial Neoplasms Adenocarcinoma Mouth Neoplasms Neoplasms, Second Primary Liver Neoplasms Neoplasms, Hormone-Dependent Pharyngeal Neoplasms Carcinoma, Small Cell Anus Neoplasms Bone Neoplasms Pelvic Neoplasms Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Genital Neoplasms, Female Precancerous Conditions Skin Neoplasms Gastrointestinal Neoplasms Hypopharyngeal Neoplasms Brain Neoplasms Thyroid Neoplasms Mammary Neoplasms, Experimental Thoracic Neoplasms Neoplasms, Multiple Primary Radiodermatitis Paranasal Sinus Neoplasms Kidney Neoplasms Osteoradionecrosis Melanoma

Chemicals and Drugs43

Cancer Vaccines Neoplasm Proteins Antineoplastic Agents Receptors, Estrogen Tumor Markers, Biological RNA, Messenger Fluorouracil Receptor, erbB-2 Cisplatin Prostate-Specific Antigen DNA, Neoplasm RNA, Small Interfering Tumor Suppressor Protein p53 Tamoxifen Receptors, Progesterone Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Antigens, Neoplasm Paclitaxel Deoxycytidine Anticarcinogenic Agents Antibodies, Monoclonal Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic Receptors, Androgen Taxoids RNA, Neoplasm Androgen Antagonists DNA-Binding Proteins BRCA2 Protein Androgens Proto-Oncogene Proteins Transcription Factors BRCA1 Protein Carcinogens Nuclear Proteins Estrogens Proto-Oncogene Proteins c-akt Protein Kinase Inhibitors Estrogen Receptor alpha

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy Dosage Radiotherapy, Conformal Early Detection of Cancer Radiometry Particle Accelerators Radiotherapy, Image-Guided Retrospective Studies Tumor Burden Radiation Dosage Organ Sparing Treatments Neoplasm Staging Radiotherapy Survival Rate Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Prognosis Dose-Response Relationship, Radiation Combined Modality Therapy Survival Analysis Dose Fractionation Risk Radiotherapy, Computer-Assisted Prospective Studies Disease-Free Survival Film Dosimetry Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Registries Xenograft Model Antitumor Assays Risk Assessment Treatment Outcome Chemotherapy, Adjuvant Neoplasm Transplantation Sensitivity and Specificity Chemoradiotherapy Blotting, Western Reproducibility of Results Odds Ratio Radiotherapy, Adjuvant Kaplan-Meier Estimate SEER Program Phantoms, Imaging Transplantation, Heterologous Tomography, X-Ray Computed Multivariate Analysis Risk Factors Feasibility Studies Questionnaires Mammography Oligonucleotide Array Sequence Analysis Imaging, Three-Dimensional Drug Screening Assays, Antitumor Proton Therapy Lymphatic Irradiation Molecular Targeted Therapy Clinical Trials as Topic Polymerase Chain Reaction Models, Biological Transfection Predictive Value of Tests Logistic Models Neoplasm Grading Tissue Array Analysis Confidence Intervals Tomography, Spiral Computed Prostatectomy Positron-Emission Tomography Gene Knockdown Techniques Flow Cytometry Incidence Mammary Neoplasms, Experimental Drug Administration Schedule Immunoenzyme Techniques Palliative Care Mastectomy Biopsy Immunotherapy Genetic Testing Cohort Studies DNA Mutational Analysis Probability

Psychiatry and Psychology1

Phenomena and Processes47

Gene Expression Regulation, Neoplastic Radiation Dosage Dose-Response Relationship, Radiation Risk Genetic Predisposition to Disease Drug Resistance, Neoplasm Mutation Sensitivity and Specificity Algorithms Odds Ratio DNA Methylation Cell Survival Genotype Cell Movement Genes, BRCA1 Down-Regulation Cell Division Polymorphism, Genetic Cell Cycle Dose-Response Relationship, Drug Cell Proliferation Cell Growth Processes Apoptosis Promoter Regions, Genetic Photons RNA Interference Transfection Up-Regulation Gene Silencing Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Genes, p53 Postmenopause Diet Genes, BRCA2 Base Sequence Gene Expression Phenotype Time Factors Signal Transduction Phosphorylation Epithelial-Mesenchymal Transition Alleles Radiation Tolerance Drug Synergism Probability

Disciplines and Occupations2

Radiation Oncology Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science13

Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy, Conformal Survival Rate Radiotherapy, Computer-Assisted Registries Algorithms SEER Program Questionnaires Imaging, Three-Dimensional Base Sequence Incidence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care36

Radiation Injuries Retrospective Studies Radiation Dosage Survival Rate Follow-Up Studies Dose-Response Relationship, Radiation Survival Analysis Risk Prospective Studies Disease-Free Survival National Cancer Institute (U.S.)Film Dosimetry Registries Risk Assessment Treatment Outcome Sensitivity and Specificity Reproducibility of Results Odds Ratio Age Factors Kaplan-Meier Estimate SEER Program Multivariate Analysis Risk Factors Feasibility Studies Questionnaires Clinical Trials as Topic American Cancer Society Predictive Value of Tests Logistic Models Confidence Intervals Incidence Palliative Care Relative Biological Effectiveness Genetic Testing Cohort Studies Probability

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy Dosage Organs at Risk Radiotherapy, Conformal Early Detection of Cancer Radiometry Prostatic Neoplasms Lung Neoplasms Breast Neoplasms Particle Accelerators Ovarian Neoplasms Head and Neck Neoplasms Radiation Injuries Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Pancreatic Neoplasms Radiation Oncology Neoplasm Invasiveness Radiotherapy, Image-Guided Carcinoma Carcinoma, Squamous Cell Retrospective Studies Gene Expression Regulation, Neoplastic Mice, Nude Cancer Vaccines Tumor Burden Radiation Dosage Organ Sparing Treatments Neoplasm Staging Radiotherapy Uterine Cervical Neoplasms Survival Rate Neoplasm Proteins Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Prognosis Dose-Response Relationship, Radiation Combined Modality Therapy Survival Analysis Dose Fractionation Carcinoma, Non-Small-Cell Lung Risk Antineoplastic Agents Radiotherapy, Computer-Assisted Genetic Predisposition to Disease Disease Progression Nasopharyngeal Neoplasms Xerostomia Prospective Studies Drug Resistance, Neoplasm Neoplasm Recurrence, Local Disease-Free Survival Urinary Bladder Neoplasms National Cancer Institute (U.S.)Rectal Neoplasms Film Dosimetry Reverse Transcriptase Polymerase Chain Reaction Cell Line, Tumor Colorectal Neoplasms Oropharyngeal Neoplasms United States Receptors, Estrogen Gene Expression Profiling Registries Xenograft Model Antitumor Assays Tumor Markers, Biological Risk Assessment Mutation RNA, Messenger Fluorouracil Survivors Receptor, erbB-2 Cisplatin Medical Oncology Treatment Outcome Chemotherapy, Adjuvant Esophageal Neoplasms Neoplasm Transplantation Sensitivity and Specificity Prostate-Specific Antigen Algorithms DNA, Neoplasm Chemoradiotherapy Neoplasms, Radiation-Induced Blotting, Western Cell Transformation, Neoplastic Endometrial Neoplasms Reproducibility of Results Odds Ratio Radiotherapy, Adjuvant Age Factors RNA, Small Interfering Kaplan-Meier Estimate Adenocarcinoma DNA Methylation SEER Program Prostate

No FAQ available that match "cancer with imrt"